Insider · CIK 0001756991

Goncalves Joana

Reports to the SEC for 2 companies · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001756991

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,400 sh	$75.48	−$106K	32,671
2026-10-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−700 sh	$76.67	−$53.7K	31,971
2026-10-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,847 sh	$74.69	−$138K	34,071
2026-10-15	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$6.84	+$23.9K	35,271
2026-10-15	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	190,063
2026-10-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,853 sh	$73.89	−$211K	35,918
2026-10-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−200 sh	$77.71	−$15.5K	31,771
2026-10-15	ORKAOruka Therapeutics, Inc. · Employee Warrant (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	161,492
2026-10-15	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	38,771
2026-09-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−947 sh	$95.71	−$90.6K	31,771
2026-09-15	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$6.84	+$23.9K	36,218
2026-09-15	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	193,563
2026-09-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,150 sh	$92.03	−$290K	34,184
2026-09-15	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	39,718
2026-09-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−100 sh	$94.22	−$9,421.72	32,718
2026-09-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,384 sh	$91.10	−$217K	37,334
2026-09-15	ORKAOruka Therapeutics, Inc. · Employee Warrant (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	164,992
2026-09-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,366 sh	$92.99	−$127K	32,818
2026-08-17	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	197,063
2026-08-17	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$6.84	+$23.9K	36,218
2026-08-17	ORKAOruka Therapeutics, Inc. · Employee Warrant (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	168,492
2026-08-17	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−300 sh	$110.52	−$33.2K	38,518
2026-08-17	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	39,718
2026-08-17	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−900 sh	$109.65	−$98.7K	38,818
2026-08-17	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,320 sh	$112.01	−$372K	35,198
2026-08-17	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,480 sh	$112.56	−$279K	32,718
2026-07-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−300 sh	$87.25	−$26.2K	32,718
2026-07-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,497 sh	$85.86	−$214K	36,821
2026-07-15	ORKAOruka Therapeutics, Inc. · Employee Warrant (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	171,992
2026-07-15	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	200,563
2026-07-15	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$6.84	+$23.9K	36,218
2026-07-15	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	39,718
2026-07-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,803 sh	$86.68	−$330K	33,018
2026-07-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−400 sh	$84.36	−$33.7K	39,318
2026-06-15	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$6.84	+$23.9K	37,165
2026-06-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−300 sh	$70.62	−$21.2K	33,665
2026-06-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−947 sh	$69.69	−$66K	32,718
2026-06-15	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	204,063
2026-06-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,064 sh	$69.42	−$352K	33,965
2026-06-15	ORKAOruka Therapeutics, Inc. · Employee Warrant (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	175,492
2026-06-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,636 sh	$68.38	−$112K	39,029
2026-06-15	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	40,665
2026-05-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,100 sh	$62.42	−$131K	33,477
2026-05-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−100 sh	$63.52	−$6,352	33,377
2026-05-15	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	207,563
2026-05-15	ORKAOruka Therapeutics, Inc. · Employee Warrant (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,500 sh	—	—	178,992
2026-05-15	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$6.84	+$23.9K	36,877
2026-05-15	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	40,377
2026-05-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,800 sh	$61.56	−$295K	35,577
2026-04-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,273 sh	$66.56	−$151K	33,877

Recent filings

Accepted (ET)
Oct 15 18:154
Goncalves Joana0000907654-26-000108
SEC(opens sec.gov)
Sep 154
Goncalves Joana0000907654-26-000098
SEC(opens sec.gov)
Aug 174
Goncalves Joana0000907654-26-000079
SEC(opens sec.gov)

Companies

Address

C/O ORUKA THERAPEUTICS, INC. 855 OAK GROVE AVE., SUITE 100

MENLO PARK, CA, 94025